Potentiation of adenosine and the adenine nucleotides by dipyridamole.
D000109:Acetylcholine / Q000494:pharmacology*; D000227:Adenine Nucleotides / Q000494:pharmacology*; D000255:Adenosine Triphosphate / Q000494:pharmacology*; D000818:Animals; D001145:Arrhythmias, Cardiac / Q000139:chemically induced; D001375:Azaguanine / Q000494:pharmacology; D001783:Blood Flow Velocity; D003331:Coronary Vessels / Q000187:drug effects; D004176:Dipyridamole / Q000494:pharmacology*; D004357:Drug Synergism; D004562:Electrocardiography; D005260:Female; D006168:Guinea Pigs; D006321:Heart / Q000187:drug effects*; D006325:Heart Atria / Q000187:drug effects; D006327:Heart Block / Q000139:chemically induced*; D006339:Heart Rate / Q000187:drug effects; D066298:In Vitro Techniques; D007422:Intestines / Q000187:drug effects; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects*; D009705:Nucleosides / Q000494:pharmacology*; D010208:Papaverine / Q000494:pharmacology; D011817:Rabbits; D014599:Uterus / Q000187:drug effects
D000227:Adenine Nucleotides; D009705:Nucleosides; D004176:Dipyridamole; D000255:Adenosine Triphosphate; D010208:Papaverine; D000109:Acetylcholine; D001375:Azaguanine